Dolby Laboratories (NYSE:DLB – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the five research firms that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $90.75.
DLB has been the topic of several recent analyst reports. Barrington Research reaffirmed an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research note on Monday, April 27th. Rosenblatt Securities reissued a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a report on Friday, January 30th. Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a report on Friday, March 27th.
Check Out Our Latest Analysis on Dolby Laboratories
Insider Transactions at Dolby Laboratories
Hedge Funds Weigh In On Dolby Laboratories
Several hedge funds have recently modified their holdings of the company. First Horizon Corp acquired a new stake in shares of Dolby Laboratories in the third quarter valued at $25,000. Hantz Financial Services Inc. boosted its stake in Dolby Laboratories by 166.7% during the third quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock valued at $25,000 after buying an additional 220 shares in the last quarter. Rothschild Investment LLC grew its holdings in Dolby Laboratories by 4,046.7% during the third quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock worth $45,000 after acquiring an additional 607 shares during the period. Migdal Insurance & Financial Holdings Ltd. acquired a new position in Dolby Laboratories during the third quarter worth about $50,000. Finally, Optiver Holding B.V. raised its position in Dolby Laboratories by 7,955.6% in the third quarter. Optiver Holding B.V. now owns 725 shares of the electronics maker’s stock worth $52,000 after acquiring an additional 716 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors and hedge funds.
Dolby Laboratories Trading Up 1.1%
NYSE DLB opened at $53.98 on Thursday. Dolby Laboratories has a 52 week low of $52.45 and a 52 week high of $77.00. The stock has a market cap of $5.11 billion, a price-to-earnings ratio of 21.34 and a beta of 0.86. The company has a 50-day moving average price of $60.42 and a two-hundred day moving average price of $63.50.
Dolby Laboratories (NYSE:DLB – Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. The company had revenue of $395.63 million for the quarter, compared to analysts’ expectations of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.34 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, equities research analysts expect that Dolby Laboratories will post 3.22 earnings per share for the current fiscal year.
Dolby Laboratories Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date was Tuesday, May 12th. Dolby Laboratories’s payout ratio is 56.92%.
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Further Reading
- Five stocks we like better than Dolby Laboratories
- The Palantir Paradox—Record Numbers and a Stock That Won’t Cooperate
- TJX Companies Fires on All Cylinders With 9% Revenue Growth
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
